These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36686492)

  • 41. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
    Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
    Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.
    Salman MA; Salman AA; Abdelsalam A; Atallah M; Shaaban HE; El-Mikkawy A; Omar MG; Elshenoufy M
    Obes Surg; 2020 Jan; 30(1):87-95. PubMed ID: 31372873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies.
    Maestri M; Santopaolo F; Pompili M; Gasbarrini A; Ponziani FR
    Front Nutr; 2023; 10():1110536. PubMed ID: 36875849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study.
    Van Olden CC; Van de Laar AW; Meijnikman AS; Aydin O; Van Olst N; Hoozemans JB; De Brauw LM; Bruin SC; Acherman YIZ; Verheij J; Pyykkö JE; Hagedoorn M; Sanderman R; Bosma NC; Tremaroli V; Lundqvist A; Olofsson LE; Herrema H; Lappa D; Hjorth S; Nielsen J; Schwartz T; Groen AK; Nieuwdorp M; Bäckhed F; Gerdes VEA
    J Intern Med; 2021 Mar; 289(3):340-354. PubMed ID: 32640105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis.
    Li HY; Huang SY; Zhou DD; Xiong RG; Luo M; Saimaiti A; Han MK; Gan RY; Zhu HL; Li HB
    J Adv Res; 2023 Oct; 52():59-72. PubMed ID: 36639024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
    Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach.
    Stols-Gonçalves D; Mak AL; Madsen MS; van der Vossen EWJ; Bruinstroop E; Henneman P; Mol F; Scheithauer TPM; Smits L; Witjes J; Meijnikman AS; Verheij J; Nieuwdorp M; Holleboom AG; Levin E
    Gut Microbes; 2023 Dec; 15(1):2223330. PubMed ID: 37317027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal Metabolome and Bacterial Composition in Severe Obesity: Impact of Diet and Bariatric Surgery.
    Salazar N; Ponce-Alonso M; Garriga M; Sánchez-Carrillo S; Hernández-Barranco AM; Redruello B; Fernández M; Botella-Carretero JI; Vega-Piñero B; Galeano J; Zamora J; Ferrer M; de Los Reyes-Gavilán CG; Del Campo R
    Gut Microbes; 2022; 14(1):2106102. PubMed ID: 35903014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota characterisation in obese patients before and after bariatric surgery.
    Campisciano G; Palmisano S; Cason C; Giuricin M; Silvestri M; Guerra M; Macor D; De Manzini N; Crocé LS; Comar M
    Benef Microbes; 2018 Apr; 9(3):367-373. PubMed ID: 29482339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.
    McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B
    Surg Obes Relat Dis; 2018 Jan; 14(1):74-80. PubMed ID: 29055669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bariatric/Metabolic Surgery Induces Noticeable Changes of Microbiota and Their Secreting Extracellular Vesicle Composition in the Gut.
    Huh YJ; Seo JY; Nam J; Yang J; McDowell A; Kim YK; Lee JH
    Obes Surg; 2019 Aug; 29(8):2470-2484. PubMed ID: 31129882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
    Poljo A; Kopf S; Sulaj A; Roessler S; Albrecht T; Goeppert B; Bojko S; Müller-Stich BP; Billeter AT
    Surg Obes Relat Dis; 2023 Dec; 19(12):1421-1434. PubMed ID: 37666725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of bariatric surgery on liver enzymes in people with obesity: A 5-year observational study.
    Elhelw O; Ragavan S; Majeed W; Alkhaffaf B; Mohammed N; Senapati S; Ammori BJ; Robinson JA; Syed AA
    Surgeon; 2024 Feb; 22(1):e26-e33. PubMed ID: 37567846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bariatric surgery and non-alcoholic fatty liver disease.
    Julià H; Benaiges D; Pedro-Botet J
    Med Clin (Barc); 2022 Jun; 158(11):550-555. PubMed ID: 35120767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality.
    Xia Y; Ren M; Yang J; Cai C; Cheng W; Zhou X; Lu D; Ji F
    Front Microbiol; 2022; 13():1003755. PubMed ID: 36204626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery.
    Wolf RM; Oshima K; Canner JK; Steele KE
    Surg Obes Relat Dis; 2019 Oct; 15(10):1766-1772. PubMed ID: 31558407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.